https://www.cancerresearchuk.org/about-cancer/treatment/drugs/daratumumab
Daratumumab is a targeted cancer drug. It is a treatment for myeloma. Find out how you have it, possible side effects and other important information.
cancer research ukdaratumumab
https://www.targetedonc.com/view/defining-high-risk-smm-applying-imwg-criteria-to-guide-daratumumab-treatment
Dec 3, 2025 - Dr. Peter Voorhees discusses risk stratification in smoldering multiple myeloma, highlighting the IMWG criteria and the benefits of daratumumab treatment.
high riskdefiningsmmapplyingcriteria
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-daratumumab-and-hyaluronidase-fihj-pomalidomide-and-dexamethasone-multiple-myeloma
FDA approves daratumumab and hyaluronidase-fihj with pomalidomide and dexamethasone for multiple myeloma
daratumumab and hyaluronidasefdapomalidomidedexamethasone
https://www.ajmc.com/view/griffin-daratumumab-plus-rvd-improved-responses-for-older-and-some-high-risk-patients-compared-with-triplet-alone-in-newly-diagnosed-mm
The analysis, which was presented during the 64th ASH Annual Meeting and Exposition, highlighted stringent complete response data for patients 65 years and...
griffindaratumumabplusrvdimproved